Patents by Inventor Suzanne Janine Paxton-Pierson

Suzanne Janine Paxton-Pierson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Androgen effectors
    Patent number: 10568900
    Abstract: The invention discloses novel endocrine treatment phytochemicals which affect androgenic status. The method for treatment of 5-alpha-reductase responsive diseases using four novel 5-alpha-reductase inhibitor compounds; leucoanthocyanidin, glabrene, glabridin, and alpha-terpineol is disclosed. Glabridin does not interfere with normal testosterone to androgen receptor binding.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: February 25, 2020
    Inventor: Suzanne Janine Paxton-Pierson
  • Androgen effectors
    Patent number: 10111895
    Abstract: The invention discloses novel endocrine treatment phytochemicals which affect androgenic status. The method for treatment of 5-alpha-reductase responsive diseases using four novel 5-alpha-reductase inhibitor compounds; leucoanthocyanidin, glabrene, glabridin, and alpha-terpineol is disclosed. Glabridin does not interfere with normal testosterone to androgen receptor binding.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: October 30, 2018
    Inventor: Suzanne Janine Paxton-Pierson
  • Novel Androgen Effectors
    Publication number: 20170151271
    Abstract: The invention discloses novel endocrine treatment phytochemicals which affect androgenic status. The method for treatment of 5-alpha-reductase responsive diseases using four novel 5-alpha-reductase inhibitor compounds; leucoanthocyanidin, glabrene, glabridin, and alpha-terpineol is disclosed. Glabridin does not interfere with normal testosterone to androgen receptor binding.
    Type: Application
    Filed: January 23, 2017
    Publication date: June 1, 2017
    Inventor: Suzanne Janine Paxton-Pierson